The filing contains no unexpected material information; traders should focus on upcoming quarterly earnings reports to assess execution against the $627.5M guidance midpoint.
Price Chart
Executive Summary
Glaukos Corp filed an 8-K attaching its May 2026 investor presentation, which reiterates financial highlights including 2025 net sales of $507M, 2026 revenue guidance midpoint of $627.5M, 84% gross margin, $281M cash with no debt, and a 10-year revenue CAGR of 20%. The presentation is a standard corporate update with no material new disclosures, so the filing is routine and non-eventful.
Key Facts
- 2025 net sales: $507 million (up from $383M in 2024)
- 2026 revenue guidance midpoint: $627.5 million
- Gross margin (1Q 2026): 84%
- Cash and equivalents: $281 million; no debt as of 3/31/2026
- 10-year revenue CAGR: 20%
- R&D investment since 2018: $800 million
Financial Impact
No new financial impact; previously disclosed guidance and results reaffirmed.
Risk Factors
- Pipeline execution and regulatory approvals (e.g., iDose TRIO, Epioxa adoption)
- Competitive pressures in interventional glaucoma and keratoconus markets
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-202466 |
| Document: d135093d8k.htm | 0001193125-26-202466 |
| Document: 0001193125-26-202466-index-headers.html | 0001193125-26-202466 |
| Document: 0001193125-26-202466-index.html | 0001193125-26-202466 |
| Document: 0001193125-26-202466.txt | 0001193125-26-202466 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Insider Cluster | $184.53 $171.09 | ▼ −7.28% | ▼ −5.29% | $165.29 (−10.43%) |
Aug 11, 2026 7w ago | Insider Cluster | $186.63 $170.38 | ▼ −8.71% | ▼ −6.81% | $165.29 (−11.43%) |
Aug 3, 2026 8w ago | 8-K | $170.87 $179.56 | ▲ +5.09% | ▲ +3.85% | $165.29 (−3.26%) |
Jul 9, 2026 12w ago | Insider Cluster | $155.07 $170.99 | ▲ +10.27% | ▲ +8.02% | $165.29 (+6.59%) |
May 4, 2026 21w ago | 8-K | $135.85 $103.12 | ▼ −24.09% | ▼ −29.74% | $165.29 (+21.67%) |
May 1, 2026 22w ago | Insider Cluster | $140.22 $103.12 | ▼ −26.46% | ▼ −31.74% | $165.29 (+17.88%) |
Mar 16, 2026 28w ago | Insider Cluster | $98.94 $120.52 | ▲ +21.81% | ▲ +18.03% | $165.29 (+67.06%) |
Mar 16, 2026 28w ago | Insider Cluster | $98.94 $120.52 | ▲ +21.81% | ▲ +18.03% | $165.29 (+67.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access